GDRX GoodRx Holdings, Inc.
XNAS
3.02
+0.00%
After hours
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
What changed
Recent filings, trades and moves- 52-Week Range
- $1.77 – $3.89
- YTD
- +9.82%
- IV Rank (30D)
- 24.88
- Straddle Price
- $1.05
- P/C Vol Ratio
- 2.73
- Market Cap
- $1.1B
- Open
- $3.37
- Day Range
- $3.01 – $3.43
- Volume
- 2,161,103
- Prev Close
- $3.36
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.12% |
| Beta vs SPY | 1.46 |
| Cost of Equity (CAPM) | 13.13% (VRP-adj) |
| WACC | 10.81% |
| Volatility Risk Premium | +76.8pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +2.2% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.02 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.2B |
| Return on Equity (TTM) | 2.5% |
| Book / Price | 55.4% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 90.8% |
| FCF Margin (TTM) | 21.2% |
| Debt / Equity | 0.74 |
| Quality Score | 3/6 — normal (10y DCF) |
| Market-Implied Growth | -4.8% (reverse-DCF on current price) |
| SMA 50 | $3.44 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $3.54 |
| Bollinger Width / SMA20 | 8.7% (drives anchor stability) |
| Net Debt | $0.2B |
| Market Cap | $1B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $5.27 | 23% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $1.43 | 6% | median 35.0× · 3 peers |
| Peer EV/EBITDA | $4.32 | 7% | median 10.1× · 3 peers |
| Peer P/B | $2.21 | 9% | median 1.2× · 3 peers |
| Peer P/S | $2.91 | 9% | median 1.3× · 3 peers |
| Market Anchor (SMA50) | $3.44 | 46% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
- Industry (SIC)
- SERVICES-COMPUTER PROCESSING & DATA PREPARATION (7374) · industry map
- Exchange
- XNAS
- Market Cap
- $1.1B
- Employees
- 697
- List Date
- 2020-09-23
- CIK
- 0001809519
- Next Earnings
- 2026-11-24 (After-Close)
- EPS Forecast
- $0.04 (3 est.)
- Headquarters
- Santa Monica, CA
- Homepage
- https://www.goodrx.com
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offe…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 11.93% | -26.01% | 18.68% | 6.76% | 4.61% | -17.45% | -0.25% |
| Feb | -10.91% | 3.59% | -10.49% | 27.08% | 5.96% | -17.98% | -0.46% |
| Mar | -15.41% | 15.47% | 13.64% | -14.97% | -9.07% | -9.68% | -3.34% |
| Apr | 2.51% | -31.15% | -22.30% | 0.00% | 4.51% | 17.41% | -4.84% |
| May | -4.48% | -41.99% | 18.56% | 12.91% | -15.52% | 14.51% | -2.67% |
| Jun | -3.87% | -21.17% | 2.79% | -3.11% | 30.37% | -6.49% | -0.25% |
| Jul | -7.31% | 1.14% | 68.31% | 15.73% | -3.43% | -1.12% | 12.22% |
| Aug | 19.33% | -3.02% | -24.68% | -9.71% | -3.97% | 10.44% | -1.94% |
| Sep | 8.03% | -18.07% | -14.05% | -11.70% | -1.63% | -4.91% | -7.05% |
| Oct | 1.43% | 9.15% | -11.65% | -11.69% | -33.00% | 6.73% | -6.50% |
| Nov | -9.09% | -18.05% | 18.85% | -21.81% | -15.11% | -14.93%* | -10.02% |
| Dec | -14.16% | -9.69% | 5.18% | -6.06% | -1.09% | -- | -5.16% |
| Total | -24.91% | -81.91% | 37.56% | -24.47% | -40.46% | -27.51% | -26.95% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
System Prompt: LLM Stock Analysis Prompt Template
Executive Summary: Overall assessment: NEUTRAL with confidence level (6/10) Key drivers and primary risks: * Technical indicators suggest a neutral market condition, with no clear trend or momentum signals. * Recent news sentiment is mixed, with both positive and negative headlines. * Risk metrics indicate high volatility, which may impact the stock's price movement.
Technical Analysis:
- Trend Direction: Neutral (short-term), Bearish (medium-term), Bullish (long-term)
- Support/Resistance Levels: Lower band ($2.75) and upper band ($3.22)
- Momentum Signals:
- RSI interpretation: Neutral (48.08)
- MACD signal: Bullish momentum
- Bollinger Bands position: Squeeze (price touching middle band)
- Volume Analysis: Volume rate of change is -88.50%, indicating a possible reversal.
News & Sentiment Analysis:
- Recent Headlines Summary: Mixed news sentiment, with 2 positive headlines and 3 negative headlines.
- Sentiment Assessment: Neutral (aggregate sentiment)
- Catalyst Identification: Wegovy HD rollout and Novo Nordisk's pricing strategy may impact the stock.
Risk & Volatility Assessment:
- Beta Interpretation: High risk relative to market (beta >1.5)
- Volatility Regime: High volatility
- Options Market Signals: IV rank is low, indicating historically low volatility.
- Downside Protection: Lower band ($2.75) may serve as support.
Market Context & Positioning:
- Sector Performance: Neutral (relative strength vs sector/market)
- Institutional Activity: No clear institutional interest signals
- Correlation Analysis: Stock moves relatively more than market (R-squared interpretation)
- Relative Valuation: Position within trading range
Key Levels & Action Items:
- Critical Price Levels: Lower band ($2.75) and upper band ($3.22)
- Breakout/Breakdown Levels: None
- Time-Sensitive Catalysts: Wegovy HD rollout and Novo Nordisk's pricing strategy
- Risk Management: Stop-loss levels around $2.70, position sizing considerations
This analysis is based on the provided data and does not include earnings information as it is not available. The technical indicators suggest a neutral market condition with no clear trend or momentum signals. Recent news sentiment is mixed, and risk metrics indicate high volatility. Options market signals show historically low volatility, and institutional activity does not provide clear interest signals.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-03-11 | After-Close | 16.52% | 10.42% | 0.63x | Within |
| 2021-05-13 | After-Close | 15.39% | 9.55% | 0.62x | Within |
| 2021-08-12 | After-Close | 6.47% | 4.36% | 0.67x | Within |
| 2021-11-10 | After-Close | 15.78% | 5.17% | 0.33x | Within |
| 2022-02-28 | After-Close | 15.69% | 38.91% | 2.48x | Exceeded |
| 2022-05-09 | After-Close | 23.81% | 25.86% | 1.09x | Exceeded |
| 2022-08-08 | After-Close | 24.48% | 0.64% | 0.03x | Within |
| 2022-11-08 | After-Close | 20.04% | 22.52% | 1.12x | Exceeded |
| 2023-02-28 | After-Close | 19.66% | 3.97% | 0.20x | Within |
| 2023-04-25 | After-Close | 5.46% | 11.48% | 2.10x | Exceeded |
| 2023-08-09 | After-Close | 10.08% | 3.90% | 0.39x | Within |
| 2023-11-09 | After-Close | 14.41% | 7.88% | 0.55x | Within |
| 2024-01-10 | After-Close | 17.77% | 1.55% | 0.09x | Within |
| 2024-02-29 | After-Close | 10.27% | 7.19% | 0.70x | Within |
| 2024-05-09 | After-Close | 10.25% | 4.76% | 0.46x | Within |
| 2024-08-08 | Pre-Market | 19.16% | 18.58% | 0.97x | Within |
| 2024-11-07 | Pre-Market | 20.46% | 17.51% | 0.86x | Within |
| 2025-02-27 | After-Close | 15.06% | 0.00% | 0.00x | Within |
| 2025-05-07 | After-Close | 29.68% | 11.87% | 0.40x | Within |
| 2025-08-06 | After-Close | 20.16% | 20.05% | 0.99x | Within |
| 2025-11-04 | Pre-Market | 37.01% | 1.51% | 0.04x | Within |
| 2026-02-25 | After-Close | 22.45% | 18.78% | 0.84x | Within |
| 2026-05-06 | After-Close | 12.65% | 10.51% | 0.83x | Within |
| 2026-08-05 | After-Close | 83.33% | 13.76% | 0.17x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
GDRX Options Activity & IV Rank
GDRX IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow · All expiries
ATM Options Pricing
Chain Summary
GDRX Implied Volatility
Loading implied volatility…
The 30-day IV is the at-the-money implied volatility of options 30 days out, the blue line. The band is its 20-session average, 2 standard deviations either side. Realized volatility is how much GDRX actually moved over the last 20 sessions, from closing prices, on the same yearly scale. Without earnings takes each earnings report out of the 30-day IV, sized from what options paid for past reports, so it shows whether options are expensive or cheap apart from the report. Click a name above the chart to show or hide it.
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Estimated net dealer gamma is at the 18th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
IV(call wing) − IV(ATM), in vol pointsThe same measure on the upside: how the OTM call is priced against the at-the-money strike.
- Negative (typical) — calls trade below ATM for most stocks and indices, so the sign alone says little.
- Percentile vs own history: high = upside calls unusually rich for this name (squeezes, takeover talk, commodity supply scares); low = calls cheaper than usual.
Put or call vs ATM tells you how expensive that tail is. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Loading the implied volatility surface…
Loading the implied volatility smile…
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
High volatility - stock moves more than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $10.6M | #1031 of 3151 | -0.9% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $1.0M | #2890 of 3716 | +1302.7% | 13F | |
| Citadel Hedge fund Ken Griffin | $300K | #5072 of 6285 | -54.2% | 13F | |
| Point72 Hedge fund Steve Cohen | $56K | #1872 of 1945 | new | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $0K | #4740 of 4858 | 0.0% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
GDRX Institutional Ownership (13F)
Filings for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC Custodian | $3.33M | 79.39% | 2026-09-30 |
| 2 | Susquehanna International Group, LLP Custodian | $487.30K | 11.61% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $196.42K | 4.68% | 2026-06-30 |
| 4 | Walleye Capital LLC Custodian | $180.95K | 4.31% | 2026-09-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $562.18K | 46.79% | 2026-06-30 |
| 2 | Walleye Capital LLC Custodian | $364.53K | 30.34% | 2026-09-30 |
| 3 | Citadel Advisors LLC Custodian | $274.75K | 22.87% | 2026-06-30 |
GDRX Insider Trading (Form 4)
Latest: 2026-11-09| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-11-09 | Ronald E Bruehlman | Director | Exer (M) | +21,692 | — | EDGAR | |
| 2026-11-03 | Trevor Bezdek | Director | Exer (M) | +34,975 | — | EDGAR | |
| 2026-10-26 | Douglas Joseph Hirsch | Director | Exer (M) | +20,521 | — | EDGAR | |
| 2026-10-15 | Thomas (TC) Chan | Chief Accounting Officer | Mixed Tax −2,948 · Exer +5,793 |
+2,845 | $3.38 | -$10.0K | EDGAR |
| 2026-10-15 | Wendy Lynn Barnes | See Remarks | Mixed Tax −120,456 · Exer +277,289 |
+156,833 | $3.38 | -$407.1K | EDGAR |
| 2026-10-15 | Justin Fengler | See Remarks | Mixed Exer +32,490 · Tax −14,247 |
+18,243 | $3.38 | -$48.2K | EDGAR |
| 2026-09-15 | Thomas (TC) Chan | Chief Accounting Officer | Mixed Exer +2,101 · Tax −1,069 |
+1,032 | $3.56 | -$3.8K | EDGAR |
| 2026-09-15 | Justin Fengler | See Remarks | Mixed Exer +3,087 · Tax −1,354 |
+1,733 | $3.56 | -$4.8K | EDGAR |
| 2026-08-26 | Francisco Partners GP IV, L.P. | 10%+ Owner | Sell (S) | −1,567,044 | $3.50 | -$5.48M | EDGAR |
| 2026-08-21 | Francisco Partners GP IV, L.P. | 10%+ Owner | Mixed Sell −1,193,951 · Conv +7,500,000 · Other −4,739,005 |
+1,567,044 | $3.52 | -$4.20M | EDGAR |
| 2026-08-17 | Justin Fengler | See Remarks | Mixed Exer +48,532 · Tax −21,407 |
+27,125 | $3.73 | -$79.8K | EDGAR |
| 2026-08-17 | Thomas (TC) Chan | Chief Accounting Officer | Mixed Exer +10,115 · Tax −5,149 |
+4,966 | $3.73 | -$19.2K | EDGAR |
| 2026-08-12 | Justin Fengler | See Remarks | Award (A) | — | — | EDGAR | |
| 2026-07-16 | Christopher A McGinnis | See Remarks | Mixed Exer +36,988 · Tax −16,294 |
+20,694 | $3.01 | -$49.0K | EDGAR |
| 2026-07-16 | Thomas (TC) Chan | Chief Accounting Officer | Mixed Exer +5,792 · Tax −2,947 |
+2,845 | $3.01 | -$8.9K | EDGAR |
GDRX Insider Holdings
17 insiders · @ $3.02| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Spectrum Equity Associates VII, L.P. | 10%+ Owner | 8,881,362 | $26.87M | -$224.56M | 3 | 2025-10-16 |
| 2 | Idea Men, LLC | Director | 7,000,000 | $21.18M | -$359.13M | 14 | 2025-03-21 |
| 3 | FRANCISCO PARTNERS IV-A, L.P. | 10%+ Owner | 6,661,202 | $20.15M | $0 | 1 | 2025-03-18 |
| 4 | Trevor Bezdek | Chairman | 5,644,226 | $17.07M | -$20.00M | 29 | 2026-11-03 |
| 5 | Douglas Joseph Hirsch | Director | 5,606,898 | $16.96M | -$20.32M | 33 | 2026-10-26 |
| 6 | Wendy Lynn Barnes | See Remarks | 898,490 | $2.72M | $0 | 6 | 2026-10-15 |
| 7 | Scott Wagner | Director | 472,997 | $1.43M | $982.7K | 19 | 2026-06-17 |
| 8 | Agnes Rey-Giraud | Director | 426,286 | $1.29M | -$5.29M | 13 | 2026-06-17 |
| 9 | Karsten Voermann | Chief Financial Officer | 363,561 | $1.10M | -$9.65M | 22 | 2025-01-08 |
| 10 | Ronald E Bruehlman | Director | 229,044 | $692.9K | $0 | 8 | 2026-11-09 |
GDRX Board & Officers
As of SEC filings through Nov 16, 2026Directors 7
- Agnes Rey-Giraud · since Sep 23, 2020
- Christopher Michael Adams · since Sep 23, 2020
- Greg Mondre · since Sep 23, 2020
- Kelly J. Kennedy · since Dec 21, 2023
- Ronald E Bruehlman · since Nov 8, 2024
- Wendy Lynn Barnes · since Jan 1, 2025
- Scott Wagner · listed since Jan 2025
Officers 4
- Wendy Lynn Barnes · Chief Executive Officer and President · since Jan 1, 2025
- Christopher A McGinnis · Chief Financial Officer & Treasurer · since Feb 4, 2025
- Justin Fengler · Chief Financial Officer and Chief Strategy & Operations Officer · since Aug 6, 2026
- Thomas (TC) Chan · Chief Accounting Officer · since Apr 23, 2026
10% owners 5
- Francisco Partners GP IV Management Ltd (entity) · since Sep 23, 2020
- Francisco Partners GP IV, L.P. (entity) · since Sep 23, 2020
- Francisco Partners IV, L.p. (entity) · since Sep 23, 2020
- Francisco Partners Iv-A, L.p. (entity) · since Sep 23, 2020
- Francisco Partners Management, LP (entity) · since Sep 23, 2020
Changes in the last 10 years (98)
| Aug 6, 2026 | Justin Fengler became Chief Financial Officer and Chief Strategy & Operations Officer |
| Apr 23, 2026 | Thomas (TC) Chan became Chief Accounting Officer |
| Mar 31, 2026 | The company announced the departure of Ian T Clark from the board in an SEC filing |
| Mar 24, 2026 | The company announced the departure of Romin Nabiey as Chief Accounting Officer in an SEC filing |
| Nov 3, 2025 | Trevor Bezdek no longer listed as Chairman in SEC filings |
| Oct 16, 2025 | Spectrum VII Investment Managers' Fund, L.P. reported in an SEC filing no longer being a 10% owner |
| Oct 16, 2025 | Spectrum VII Co-Investment Fund, L.P. reported in an SEC filing no longer being a 10% owner |
| Oct 16, 2025 | Spectrum Equity VII, L.P. reported in an SEC filing no longer being a 10% owner |
| Oct 16, 2025 | Spectrum Equity Associates VII, L.P. reported in an SEC filing no longer being a 10% owner |
| Oct 16, 2025 | SEA VII Management, LLC reported in an SEC filing no longer being a 10% owner |
| Mar 21, 2025 | Idea Men, LLC first listed as a director in an SEC filing |
| Feb 4, 2025 | Christopher A McGinnis became Chief Financial Officer & Treasurer |
| Jan 23, 2025 | Scott Wagner first listed as a director in an SEC filing |
| Jan 21, 2025 | The company announced the departure of Simon Patterson from the board in an SEC filing |
| Jan 1, 2025 | Wendy Lynn Barnes became a director |
| Jan 1, 2025 | Wendy Lynn Barnes became Chief Executive Officer and President |
| Dec 12, 2024 | The company announced the departure of Scott Wagner as Interim Chief Executive Officer in an SEC filing |
| Nov 8, 2024 | Ronald E Bruehlman became a director |
| Oct 28, 2024 | Douglas Joseph Hirsch no longer listed as Chief Mission Officer in SEC filings |
| Oct 22, 2024 | The company announced the departure of Julie MB Bradley from the board in an SEC filing |
| Sep 3, 2024 | Spectrum VII Investment Managers' Fund, L.P. no longer listed as a director in SEC filings |
| Sep 3, 2024 | Spectrum VII Investment Managers' Fund, L.P. first listed as a 10% owner in an SEC filing |
| Sep 3, 2024 | Spectrum VII Co-Investment Fund, L.P. no longer listed as a director in SEC filings |
| Sep 3, 2024 | Spectrum VII Co-Investment Fund, L.P. first listed as a 10% owner in an SEC filing |
| Sep 3, 2024 | Spectrum Equity VII, L.P. no longer listed as a director in SEC filings |
| Sep 3, 2024 | Spectrum Equity Associates VII, L.P. no longer listed as a director in SEC filings |
| Sep 3, 2024 | SEA VII Management, LLC no longer listed as a director in SEC filings |
| Jul 8, 2024 | Ian T Clark became a director |
| May 29, 2024 | Simon Patterson became a director |
| Feb 23, 2024 | The company announced the departure of Raj Beri as Chief Operating Officer in an SEC filing |
| Dec 21, 2023 | Kelly J. Kennedy became a director |
| Nov 21, 2023 | Spectrum VII Investment Managers' Fund, L.P. no longer listed as a 10% owner in SEC filings |
| Nov 21, 2023 | Spectrum VII Investment Managers' Fund, L.P. first listed as a director in an SEC filing |
| Nov 21, 2023 | Spectrum VII Co-Investment Fund, L.P. no longer listed as a 10% owner in SEC filings |
| Nov 21, 2023 | Spectrum VII Co-Investment Fund, L.P. first listed as a director in an SEC filing |
| Nov 21, 2023 | Spectrum Equity VII, L.P. first listed as a director in an SEC filing |
| Nov 21, 2023 | Spectrum Equity Associates VII, L.P. first listed as a director in an SEC filing |
| Nov 21, 2023 | SEA VII Management, LLC first listed as a director in an SEC filing |
| Nov 17, 2023 | Scott Wagner listed as Interim Chief Executive Officer (previously Interim Chief Executive Office) in SEC filings |
| Jun 27, 2023 | The company announced the departure of Babak Azad as Chief Marketing Officer and SVP, Marketing & Communications in an SEC filing |
| Jun 5, 2023 | Trevor Bezdek listed as Chairman (previously Co-CEO) in SEC filings |
| Jun 5, 2023 | The company announced the departure of Jacqueline B Kosecoff from the board in an SEC filing |
| Jun 5, 2023 | Douglas Joseph Hirsch listed as Chief Mission Officer (previously Co-CEO) in SEC filings |
| Apr 25, 2023 | The company announced the departure of Trevor Bezdek from the board in an SEC filing |
| Apr 25, 2023 | The company announced the departure of Douglas Joseph Hirsch from the board in an SEC filing |
| Apr 25, 2023 | Scott Wagner became Interim Chief Executive Office |
| May 23, 2022 | Raj Beri became Chief Operating Officer |
| May 3, 2022 | The company announced the departure of Andrew Slutsky as President, Consumer in an SEC filing |
| Apr 20, 2022 | The company announced the departure of Karsten Voermann as Chief Financial Officer in an SEC filing |
| Apr 20, 2022 | Romin Nabiey became Chief Accounting Officer |
| Dec 22, 2021 | Colin T. Moran reported in an SEC filing no longer being a 10% owner |
| Dec 22, 2021 | Abdiel Qualified Master Fund LP reported in an SEC filing no longer being a 10% owner |
| Dec 22, 2021 | Abdiel Capital Management, LLC reported in an SEC filing no longer being a 10% owner |
| Dec 22, 2021 | Abdiel Capital LP reported in an SEC filing no longer being a 10% owner |
| Dec 22, 2021 | Abdiel Capital Advisors, LP reported in an SEC filing no longer being a 10% owner |
| Aug 30, 2021 | Colin T. Moran became a 10% owner |
| Aug 30, 2021 | Abdiel Qualified Master Fund LP became a 10% owner |
| Aug 30, 2021 | Abdiel Capital Management, LLC became a 10% owner |
| Aug 30, 2021 | Abdiel Capital LP became a 10% owner |
| Aug 30, 2021 | Abdiel Capital Advisors, LP became a 10% owner |
| Sep 23, 2020 | Trevor Bezdek became a director |
| Sep 23, 2020 | Trevor Bezdek became Co-CEO |
| Sep 23, 2020 | Stephen LeSieur became a director |
| Sep 23, 2020 | Stephen LeSieur became a 10% owner |
| Sep 23, 2020 | Spectrum VII Investment Managers' Fund, L.P. became a 10% owner |
| Sep 23, 2020 | Spectrum VII Co-Investment Fund, L.P. became a 10% owner |
| Sep 23, 2020 | Spectrum Equity VII, L.P. became a 10% owner |
| Sep 23, 2020 | Spectrum Equity Associates VII, L.P. became a 10% owner |
| Sep 23, 2020 | Slta V (gp), L.l.c. became a director |
| Sep 23, 2020 | Slta V (gp), L.l.c. became a 10% owner |
| Sep 23, 2020 | Silver Lake Technology Associates V, L.P. became a director |
| Sep 23, 2020 | Silver Lake Technology Associates V, L.P. became a 10% owner |
| Sep 23, 2020 | Silver Lake Group, L.L.C. became a director |
| Sep 23, 2020 | Silver Lake Group, L.L.C. became a 10% owner |
| Sep 23, 2020 | SLP Geology GP, L.L.C. became a director |
| Sep 23, 2020 | SLP Geology GP, L.L.C. became a 10% owner |
| Sep 23, 2020 | SLP Geology Aggregator, L.P. became a director |
| Sep 23, 2020 | SLP Geology Aggregator, L.P. became a 10% owner |
| Sep 23, 2020 | SEA VII Management, LLC became a 10% owner |
| Sep 23, 2020 | Karsten Voermann became Chief Financial Officer |
| Sep 23, 2020 | Julie MB Bradley became a director |
| Sep 23, 2020 | Jacqueline B Kosecoff became a director |
| Sep 23, 2020 | Idea Men, LLC became a 10% owner |
| Sep 23, 2020 | Greg Mondre became a director |
| Sep 23, 2020 | Francisco Partners Management, LP became a 10% owner |
| Sep 23, 2020 | Francisco Partners Iv-A, L.p. became a 10% owner |
| Sep 23, 2020 | Francisco Partners IV, L.p. became a 10% owner |
| Sep 23, 2020 | Francisco Partners GP IV, L.P. became a 10% owner |
| Sep 23, 2020 | Francisco Partners GP IV Management Ltd became a 10% owner |
| Sep 23, 2020 | Douglas Joseph Hirsch became a director |
| Sep 23, 2020 | Douglas Joseph Hirsch became Co-CEO |
| Sep 23, 2020 | Dipanjan Deb became a director |
| Sep 23, 2020 | Christopher Michael Adams became a director |
| Sep 23, 2020 | Bansi Nagji became President, Healthcare |
| Sep 23, 2020 | Babak Azad became Chief Marketing Officer and SVP, Marketing & Communications |
| Sep 23, 2020 | Andrew Slutsky became President, Consumer |
| Sep 23, 2020 | Agnes Rey-Giraud became a director |
| Sep 23, 2020 | Adam Karol became a director |
- Prev
- 1
- …
Not reported recently (10)
- Idea Men, LLC · Last reported as a 10% owner in an SEC filing dated Mar 21, 2025
- Dipanjan Deb · Last reported as a director in an SEC filing dated Jun 14, 2023
- Stephen LeSieur · Last reported as a director in an SEC filing dated Jun 14, 2023
- Adam Karol · Last reported as a director in an SEC filing dated Jun 14, 2022
- Bansi Nagji · Last reported as President, Healthcare in an SEC filing dated Oct 21, 2021
- Silver Lake Technology Associates V, L.P. · Last reported as a director in an SEC filing dated May 26, 2021
- SLP Geology Aggregator, L.P. · Last reported as a director in an SEC filing dated May 26, 2021
- SLP Geology GP, L.L.C. · Last reported as a director in an SEC filing dated May 26, 2021
- Slta V (gp), L.l.c. · Last reported as a director in an SEC filing dated May 26, 2021
- Silver Lake Group, L.L.C. · Last reported as a director in an SEC filing dated May 26, 2021
GDRX Proposed Insider Sales (Form 144)
Latest: 2026-08-19What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-08-19 | Francisco Partners GP IV, L.P. | 10% Stockholder, Affiliate | 2,760,995 | $10.27M | 2026-08-19 | Merrill Lynch, Pierce,Fenner & S… | — | EDGAR |
| 2026-05-13 | IAN THORNTON CLARK | Director | 43,100 | $111.6K | 2026-05-13 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2025-10-15 | Spectrum VII Co-Investment Fund, L.P. | Affiliate | 8,569 | $34.4K | 2025-10-15 | Merrill Lynch, Pierce,Fenner & S… | — | EDGAR |
| 2025-10-15 | Spectrum VII Investment Managers' Fund, L.P. | Affiliate | 15,202 | $61.1K | 2025-10-15 | Merrill Lynch, Pierce,Fenner & S… | — | EDGAR |
| 2025-09-05 | Spectrum VII Investment Managers' Fund, L.P. | Affiliate | 10,243 | $41.0K | 2025-09-05 | Merrill Lynch, Pierce, Fenner & … | — | EDGAR |
| 2025-09-05 | Spectrum VII Co-Investment Fund, L.P. | Affiliate | 5,773 | $23.1K | 2025-09-05 | Merrill Lynch, Pierce, Fenner & … | — | EDGAR |
| 2025-07-03 | Spectrum VII Investment Managers' Fund, L.P. | Affiliate | 6,828 | $32.2K | 2025-07-03 | Merrill Lynch, Pierce, Fenner & … | — | EDGAR |
| 2025-07-03 | Spectrum VII Co-Investment Fund, L.P. | Affiliate | 3,849 | $18.1K | 2025-07-03 | Merrill Lynch, Pierce, Fenner & … | — | EDGAR |
| 2025-06-06 | Spectrum VII Investment Managers' Fund, L.P. | Affiliate | 6,828 | $27.3K | 2025-06-06 | Merrill Lynch, Pierce, Fenner & … | — | EDGAR |
| 2025-06-06 | Spectrum VII Co-Investment Fund, L.P. | Affiliate | 3,849 | $15.4K | 2025-06-06 | Merrill Lynch, Pierce, Fenner & … | — | EDGAR |
| Filing Date | Accession | Link |
|---|
| Filing Date | Accession | Link |
|---|---|---|
| 2026-08-05 | 0001809519-26-000152 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $8.0M | — | 2026-10-31 |
| 2 | DFSV Dimensional US Small Cap Value ETF | Dimensional | 0.02% | $4.8M | — | 2026-11-17 |
| 3 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $3.7M | — | 2026-10-31 |
| 4 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.00% | $3.5M | — | 2026-10-31 |
| 5 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.01% | $3.1M | — | 2026-11-17 |
| 6 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.00% | $2.3M | — | 2026-10-31 |
| 7 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.01% | $1.6M | — | 2026-08-31 |
| 8 | VHT Vanguard Health Care ETF | Vanguard | 0.00% | $941,358 | — | 2026-10-31 |
| 9 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.00% | $909,647 | — | 2026-11-17 |
| 10 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.00% | $902,273 | — | 2026-11-17 |
| 11 | PRFZ Invesco RAFI US 1500 Small-Mid ETF | Nport | 0.03% | $726,285 | — | 2026-07-31 |
| 12 | SFLO VictoryShares Small Cap Free Cash Flow ETF | Nport | 0.11% | $652,044 | — | 2026-06-30 |
| 13 | DSMC Distillate Small/Mid Cash Flow ETF | Nport | 0.48% | $617,728 | — | 2026-06-30 |
| 14 | AVSC Avantis U.S. Small Cap Equity ETF | Avantis | 0.02% | $577,876 | $3.1B | 2026-11-17 |
| 15 | EES WisdomTree U.S. SmallCap Fund | Nport | 0.07% | $488,186 | — | 2026-06-30 |
| 16 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $444,101 | $93.0B | 2026-11-17 |
| 17 | SCHB Schwab U.S. Broad Market ETF | Nport | 0.00% | $438,082 | — | 2026-08-31 |
| 18 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.00% | $302,969 | — | 2026-11-17 |
| 19 | PKW Invesco BuyBack Achievers ETF | Invesco | 0.01% | $216,764 | — | 2026-11-17 |
| 20 | HAPS Harbor Human Capital Factor US Small Cap ETF | Nport | 0.12% | $209,494 | — | 2026-07-31 |
| 21 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $188,206 | — | 2026-11-17 |
| 22 | SQLV Royce Quant Small-Cap Quality Value ETF | Franklin | 0.47% | $180,350 | $38.7M | 2026-11-17 |
| 23 | DXUV Dimensional US Vector Equity ETF | Dimensional | 0.00% | $174,260 | — | 2026-11-17 |
| 24 | FHLC Fidelity MSCI Health Care Index ETF | Fidelity | 0.00% | $165,047 | $4.1B | 2026-11-17 |
| 25 | HEAL Global X HealthTech ETF | Global X | 0.26% | $91,217 | — | 2026-11-18 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $200.41M | $8.54M | $0.02 | $80.83M |
| Q1 '26 | 2026-03-31 | $194.01M | $1.17M | $0.00 | $11.84M |
| Q4 '25 | 2025-12-31 | $194.78M | $5.42M | $0.02 | $32.89M |
| Q3 '25 | 2025-09-30 | $196.03M | $1.12M | $0.00 | $76.02M |
| Q2 '25 | 2025-06-30 | $203.07M | $12.84M | $0.04 | $49.58M |
| Q1 '25 | 2025-03-31 | $202.97M | $11.05M | $0.03 | $9.41M |
| Q4 '24 | 2024-12-31 | $198.58M | $6.74M | $0.02 | $44.74M |
| Q3 '24 | 2024-09-30 | $195.25M | $3.96M | $0.01 | $86.86M |
| Q2 '24 | 2024-06-30 | $200.61M | $6.69M | $0.02 | $9.70M |
| Q1 '24 | 2024-03-31 | $197.88M | $-1.01M | — | $42.59M |
| Q4 '23 | 2023-12-31 | $196.64M | $-25.87M | $-0.06 | $15.87M |
| Q3 '23 | 2023-09-30 | $179.96M | $-38.49M | $-0.09 | $60.27M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
GDRX vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| VEEV Veeva Systems Inc. | $44.9B | 43.2 | +16.5% | +20.2% | 100 |
| GDDY GoDaddy Inc | $12.5B | 14.0 | +6.4% | −13.6% | 13 |
| TEM Tempus AI, Inc. Class A Common Stock | $11.6B | — | +36.6% | −3.8% | 74 |
| HNGE Hinge Health, Inc. | $9.3B | 68.2 | +49.9% | +137.9% | 31 |
| DOCS Doximity, Inc. | $5.5B | 41.2 | +6.5% | −31.4% | 8 |
| WAY Waystar Holding Corp. Common Stock | $5.3B | 39.0 | +21.4% | −14.2% | 48 |
| DXC DXC Technology Company | $2.2B | 19.7 | −2.8% | −4.8% | 0 |
| OMCL Omnicell Inc | $1.6B | 34.1 | +5.6% | −26.8% | 19 |
| GDRX GoodRx Holdings, Inc. Class A Common Sto | $1.1B | 75.6 | −1.8% | +10.0% | 25 |
| Peer median | $7.4B | 39.0 | +11.5% | −9.2% | 25 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.